Using Segway for sensory training to improve motor and cognitive function in Parkinson's disease
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
This study is testing if using a Segway for sensory training can help people with Parkinson's disease improve their balance and brain function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 50 Years to 85 Years |
| Sex | All |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT05982730 on ClinicalTrials.gov |
What this trial studies
This study investigates the safety and effectiveness of sensory-augmented postural training using a Segway platform for individuals with Parkinson's disease. It focuses on integrating multiple sensory inputs to enhance motor control and balance. Participants will undergo a one-week training program, with assessments conducted before, immediately after, and one week post-training to evaluate changes in postural sway, walking performance, and brain activation. The study aims to provide insights into how augmented sensory information can improve motor and cognitive functions in this population.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 to 85 with moderate Parkinson's disease and balance issues.
Not a fit: Patients with other neurological disorders, major unstable medical illnesses, or significant sensory/musculoskeletal disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance balance and cognitive function in individuals with Parkinson's disease.
How similar studies have performed: While this approach is innovative, similar studies exploring sensory integration in motor training have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * a clinical diagnosis of idiopathic PD with moderate disease stage presenting balance alterations (Hoehn and Yahr stage III) * being stable on medication for at least 1 month * the ability to stand and walk unsupported for 5 min both on and off medication * age between 50 and 85 Exclusion Criteria: * neurological disorders other than PD * major unstable medical illnesses * sensory or musculoskeletal disorders (e.g., diabetes, uncorrected visual problems, arthritis, severe hearing impairments) that will prohibit the ability to perform the assessment tests and receive training
Where this trial is running
Dallas, Texas
- University of Texas Southwestern Medical Center — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Yasin Dhaher, Ph.D. — University of Texas Southwestern Medical Center
- Study coordinator: Yu-Chen Chung, PT, Ph.D.
- Email: yu-chen.chung@utsouthwestern.edu
- Phone: 214-648-8838
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.